NCT02802267 - Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG

Inecalcitol

vitamin D receptor agonist

DRUG

Placebo Oral Tablet

placebo

Trial Locations (8)

RECRUITING

Duke Cancer Institute, Duke Univ Medical Center, Durham

RECRUITING

Georgia Cancer Center-Augusta University, Augusta

NOT_YET_RECRUITING

ProHealth Care Inc, Waukesha

RECRUITING

Necker Hospital- APHP, Paris

RECRUITING

University of Texas; M D Anderson Cancer Center, Houston

RECRUITING

New Mexico Cancer Care Alliance, Albuquerque

RECRUITING

Comprehensive Cancer Centers of Nevada, Las Vegas

RECRUITING

Scripps Health, San Diego